Fresnillo AstraZeneca Climbs, Argenx Surges

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Fresnillo shares rise alongside other British mining companies as copper advances towards a record, with a key spread in London widening to extreme levels in a sign of competition for prompt supply.
- AstraZeneca shares rise as much as 1.4% after the pharmaceutical giant said it is stopping a clinical trial of the experimental drug volrustomig, which didn’t look set to help fight lung cancer better than existing therapies.
- Argenx shares jump as much as 10%, the most in more than a year, after the company announced positive late-stage trial results for its experimental myositis treatment.

See omnystudio.com/listener for privacy information.